SyncoZymes

nūhou

Nūhou maikaʻi: Ua ʻike ʻia ʻo Shangke Bio ma ke ʻano he papahana hoʻololi hoʻokō kiʻekiʻe

Ma Ianuali 5, 2021, ua loaʻa iā Shangke Biopharmaceutical (Shanghai) Co., Ltd. ka "(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine" Shanghai High-tech Achievement Transformation Project.

Ma ke ʻano he ʻoihana ʻenehana kiʻekiʻe o ke aupuni, lawe mau ʻo Suntech Biotech i ka biotechnology e alakaʻi i ka hoʻomohala ʻana i ka ʻoihana kemika a me ka lāʻau lapaʻau, a lawe mai i ka ʻōmaʻomaʻo a me ke olakino i nā kānaka e like me kāna misionari.E hoʻonui i ka ʻoihana ma nā ʻano he nui, e hui pū me nā kula kaulana a me nā ʻoihana ma ka home a me nā ʻāina ʻē, e hoʻomohala mau i kona hiki ke hoʻomohala pono, e hoʻonui i ka hoʻonohonoho kūloko o ka ʻoihana, a lilo i ʻoi aku ka maikaʻi a me ka ikaika.

hoʻokō ʻenehana kiʻekiʻe

Ka inoa papahana: (S)-1-tert-Butoxycarbonyl-3-hydroxypiperidine
'ikamu helu: 202010694
Kaulana 'ikamu: B
Inā loaʻa nā mea i hoʻokō ʻia ma ke kahua ʻenehana kiʻekiʻe me nā kuleana waiwai naʻauao kūʻokoʻa: ʻAe

Hoʻohana: (S) -1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) he mea koʻikoʻi koʻikoʻi no ka hoʻohui ʻana i nā API ibrutinib.ʻO Ibrutinib kahi lāʻau anticancer hou e huli ana i nā maʻi maʻi B-cell i ʻae ʻia ma lalo o ka ʻae ʻia e ka US Food and Drug Administration (FDA) ma Nowemapa 13, 2013 no ka mālama ʻana i ka lymphoma.

Wehewehe ʻana o ka hoʻololi hoʻokō ʻenehana kiʻekiʻe
ʻO ka hoʻololi ʻana o nā hoʻokō kiʻekiʻe-tech e pili ana i ke kaʻina hana e hana ai nā ʻoihana i ka hana ʻenehana kiʻekiʻe a me ka hana.Kākoʻo ka mokuʻāina i nā ʻoihana e hoʻokō i ka hoʻololi ʻana i nā hana ʻepekema a me ka ʻenehana ma o ka noiʻi kūʻokoʻa a me ka hoʻomohala ʻana, ka hāʻawi ʻana i nā laikini, ka lawe ʻana i nā ʻāpana ma ke kumukūʻai, a me ka hui pū ʻana me nā ʻoihana, nā kulanui a me nā keʻena noiʻi.No nā papahana hoʻololi hoʻokō ʻenehana kiʻekiʻe i loiloi ʻia a hōʻike ʻia e ka ʻoihana, e like me ka hoʻopau ʻana o kāna mau hōʻailona waiwai holoʻokoʻa a me nā ʻano o nā kuleana waiwai naʻauao o ka papahana, ke kiʻekiʻe o ka hana hou, a me nā mea ʻē aʻe, pili kāna waiwai R&D i ka papahana. - pili i nā kuleana waiwai naʻauao, nā palapala patent invention, a i ʻole nā ​​​​mea e komo ana i ke kahua hoʻokolokolo substantive.ʻO ka palapala hoʻohanohano i hāʻawi ʻia i ka ʻoihana ma hope o ka loiloi koʻikoʻi a me ka noiʻi ʻana i ka mākeke, e like me nā mea hōʻoia o ka noi patent invention, palapala patent model utility, palapala hoʻopaʻa inoa kope kope, palapala hoʻopaʻa inoa hoʻolālā hoʻonohonoho circuit circuit, etc.

ʻIkepili Hui
Ua hoʻokumu ʻia ʻo Shangke Biomedical (Shanghai) Co., Ltd. ma 2008 a aia ma ka International Medical Park, ka ʻāpana hema o Zhangjiang Hi-Tech Park, Pudong, Shanghai.He lālā paʻa loa ia o Zhejiang Shangke Biomedical Co., Ltd. ʻO Shangke Bio ua kūpaʻa i ka noiʻi a me ka hoʻomohala ʻana i ka māla lāʻau ʻōmaʻomaʻo ʻoi loa, alakaʻi i ka hoʻomohala ʻana i ka ʻoihana lāʻau kemika me ka biotechnology ʻōmaʻomaʻo, a hāʻawi i nā mea hou. nā huahana a me nā lawelawe kūlana kiʻekiʻe no ka ʻoihana lāʻau lapaʻau.He ʻoihana ʻenehana kiʻekiʻe ma Shanghai a he ʻoihana ʻenehana kiʻekiʻe ʻo Shanghai "Specialized, refined, special and new" ʻoihana.

ʻO ka ʻoihana nui a Suntech e pili ana: ka hoʻomohala ʻana a me ka hoʻohana ʻana i nā enzyme biological, ka hoʻomohala ʻana a me ka hana ʻana o nā mea waena lāʻau lapaʻau, nā API a me nā kemika hana.ʻO nā huahana nui o ka hui nā huahana coenzyme, me ka NMN, NAD, NADP, NADH, NADPH, nā enzyme biological, pharmaceutical raw material and intermediates.ʻO nā mea kūʻai aku a me nā hoa hana o ka hui ma ka honua holoʻokoʻa, a ua hoʻokumu ia i nā pilina pili pili me nā hui lāʻau lapaʻau he nui ma ʻAmelika ʻĀkau, ʻEulopa, India a me Kina.


Ka manawa hoʻouna: Jan-15-2021